Dmitry Balyasny’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-63,487
| Closed | -$5.47M | – | 3195 |
|
|
2026
Q1 | $5.47M | Buy |
+63,487
| New | +$5.7M | 0.01% | 1332 |
|
|
2025
Q2 | – | Sell |
-4,969
| Closed | -$364K | – | 3016 |
|
|
2025
Q1 | $364K | Buy |
+4,969
| New | +$411K | ﹤0.01% | 2381 |
|
|
2024
Q1 | – | Sell |
-6,800
| Closed | -$362K | – | 2804 |
|
|
2023
Q4 | $362K | Sell |
6,800
-505,672
| -99% | -$24.6M | ﹤0.01% | 2090 |
|
|
2023
Q3 | $25.4M | Buy |
512,472
+292,001
| +132% | +$16.3M | 0.05% | 493 |
|
|
2023
Q2 | $13.1M | Sell |
220,471
-282,039
| -56% | -$16.1M | 0.03% | 665 |
|
|
2023
Q1 | $28.5M | Buy |
+502,510
| New | +$32.2M | 0.07% | 404 |
|
|
2022
Q2 | – | Sell |
-444,610
| Closed | -$32.8M | – | 2903 |
|
|
2022
Q1 | $32.8M | Buy |
444,610
+121,620
| +38% | +$8.45M | 0.1% | 260 |
|
|
2021
Q4 | $23.3M | Buy |
322,990
+124,486
| +63% | +$9.04M | 0.08% | 351 |
|
|
2021
Q3 | $15.2M | Buy |
198,504
+31,751
| +19% | +$2.55M | 0.06% | 418 |
|
|
2021
Q2 | $12.9M | Sell |
166,753
-161,648
| -49% | -$11.5M | 0.06% | 423 |
|
|
2021
Q1 | $20.3M | Buy |
328,401
+256,696
| +358% | +$16.3M | 0.1% | 277 |
|
|
2020
Q4 | $4.68M | Buy |
+71,705
| New | +$4.12M | 0.03% | 672 |
|
|
2020
Q1 | – | Sell |
-418,701
| Closed | -$24.7M | – | 1279 |
|
|
2019
Q4 | $24.7M | Buy |
418,701
+383,018
| +1,073% | +$20.8M | 0.15% | 212 |
|
|
2019
Q3 | $1.82M | Buy |
35,683
+9,379
| +36% | +$447K | 0.01% | 728 |
|
|
2019
Q2 | $1.11M | Buy |
+26,304
| New | +$1.14M | 0.01% | 1046 |
|
|
2018
Q4 | – | Sell |
-7,832
| Closed | -$445K | – | 1517 |
|
|
2018
Q3 | $445K | Sell |
7,832
-99,235
| -93% | -$5.22M | ﹤0.01% | 1412 |
|
|
2018
Q2 | $5.4M | Sell |
107,067
-229,813
| -68% | -$12M | 0.02% | 640 |
|
|
2018
Q1 | $16.8M | Buy |
336,880
+244,932
| +266% | +$11.5M | 0.07% | 376 |
|
|
2017
Q4 | $3.78M | Buy |
91,948
+80,074
| +674% | +$2.8M | 0.01% | 948 |
|
|
2017
Q3 | $353K | Buy |
+11,874
| New | +$363K | ﹤0.01% | 1465 |
|
|
2017
Q2 | – | Sell |
-54,496
| Closed | -$1.61M | – | 1560 |
|
|
2017
Q1 | $1.61M | Buy |
+54,496
| New | +$1.49M | 0.01% | 963 |
|
|
2013
Q3 | – | Sell |
-108,462
| Closed | -$1.83M | – | 619 |
|
|
2013
Q2 | $1.83M | Buy |
+108,462
| New | +$1.67M | 0.03% | 447 |
|
Other funds holding GMED
JT
SC
Dmitry Balyasny's GMED Position: Q2 2026 in Review
Dmitry Balyasny sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 63,487 shares — an estimated $5.47M sold.
Dmitry Balyasny first reported a position in GMED in Q2 2013 and held it in 22 quarters. The position peaked at $32.8M in Q1 2022. 593 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Dmitry Balyasny reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
- Dmitry Balyasny sold 63,487 Globus Medical shares in Q2 2026, an estimated $5.47M.
- Dmitry Balyasny first reported a position in Globus Medical in Q2 2013 and held it in 22 quarters.
- Dmitry Balyasny's Globus Medical position peaked at $32.8M in Q1 2022.
- 593 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.